prof. dr. H.M. (Helena) Verkooijen
prof. dr. H.M. (Helena) Verkooijen
- Clinical Trial Office
Research Programs
Biography
Biography
Professor of Evaluation of Image-Guided Treatment, dedicated to improve the life of people with cancer. Committed to full integration of clinical research in routine patient care in order to facilitate undelayed evidence-based implementation of innovations in oncology.
Leader (PI) of several international (H2020) research consortia and academic industrial partnership, head of clinical research office and investigator in a range of (international) scientific studies. Strong background in teaching and development of educational modules at graduate and postgraduate level. Large international academic experience in Europe and Asia. Experienced speaker, moderator, and panel member.
Within the Division of Imaging and Cancer of the UMC Utrecht, I am responsible for clinical evaluation of innovative cancer treatments, and for evaluating to what extent theoretical benefits of these innovations translate into real benefits for patients. I lead a team of post-doc researchers, PhD students, and (medical) graduate students. I also lead the division’s clinical research office, which is responsible for trial support, data management, IT solutions, quality control and medico-ethical advise (supporting 200 academic researchers).
I lead two international consortia (one H2020 European, one transatlantic) and collaborate closely with (international) academic and industry partners. I am regularly invited as speaker at international conferences, educational sessions and consortium meetings, and as panelist at meetings/debates of professional organizations. I serve as a member in several scientific advisory boards and expert committees.
I am Strategic Advisor for 'NTvG Gezonde Zorg', a campaign of the Dutch Journal of Medicine (Nederlands Tijdschrift voor Geneeskunde). This campaign contributes to ensuring sustainability and affordability of health care in the Netherlands by exposing the harms of medicalisation (overdiagnosis and overtreatment) and explicitly demonstrating the power of (primary) prevention.
Side Activities
- Board Member Dutch Breast Cancer Research Group (Borstkanker Onderzoek Groep, BOOG)
- Member Scientific Advisory Board Dutch Expert Centre for Screening
- Board Member J.M. Fentener van Vlissingen Fonds
Research Output (347)
Vasmel Jeanine E., Groot Koerkamp Maureen L., Mandija Stefano, Veldhuis Wouter B., Moman Maaike R., Froeling Martijn, van der Velden Bas H.M., Charaghvandi Ramona K., Vreuls Celien P.H., van Diest Paul J., van Leeuwen A. M.Gijs, van Gorp Joost, Philippens Marielle E.P., van Asselen Bram, Lagendijk Jan J.W., Verkooijen Helena M., van den Bongard H. J.G.Desirée, Houweling Antonetta C. 8 Apr 2022, In: Advances in Radiation Oncology. 7 , p. 1-11
van Velzen Sanne G M, Gal Roxanne, Teske Arco J, van der Leij Femke, van den Bongard Desirée H J G, Viergever Max A, Verkooijen Helena M, Išgum Ivana 1 Mar 2022, In: International Journal of Radiation Oncology Biology Physics. 112 , p. 621-632 12 p.
van Velzen Sanne G M, Bruns Steffen, Wolterink Jelmer M, Leiner Tim, Viergever Max A, Verkooijen Helena M, Išgum Ivana 1 Mar 2022, In: International Journal of Radiation Oncology Biology Physics. 112 , p. 611-620 10 p.
Verweij Maaike E., Hoendervangers Sieske, Couwenberg Alice M., Burbach J. P.Maarten, Berbee Maaike, Buijsen Jeroen, Roodhart Jeanine, Reerink Onne, Pronk Apollo, Consten Esther C.J., Smits Anke B., Heikens Joost T., van Grevenstein W. Helma M.U., Intven Martijn P.W., Verkooijen H. Lenny M. 1 Mar 2022, In: International Journal of Radiation Oncology Biology Physics. 112 , p. 694-703 10 p.
Pielkenrood Bart J, Gal Roxanne, Kasperts Nicolien, Verhoeff Joost Jc, Bartels Marcia Mtj, Seravalli Enrica, van der Linden Yvette M, Monninkhof Evelyn M, Verlaan Jorrit-Jan, van der Velden Joanne M, Verkooijen Helena M 10 Jan 2022, In: International Journal of Radiation Oncology Biology Physics. 112 , p. 1203-1215 13 p.
Teunissen F. R., Wortel R. C., Wessels F. J., Claes A., van de Pol S. M.G., Rasing M. J.A., Meijer R. P., van Melick H. H.E., de Boer J. C.J., Verkooijen H. M., van der Voort van Zyp J. R.N. Jan 2022, In: Clinical and translational radiation oncology. 32 , p. 29-34 6 p.
Groen Veerle H, van Schie Marcel, Zuithoff Nicolaas P A, Monninkhof Evelyn M, Kunze-Busch Martina, de Boer Johannes C J, van der Voort van Zijp Jochem, Pos Floris J, Smeenk Robert Jan, Haustermans Karin, Isebaert Sofie, Draulans Cédric, Depuydt Tom, Verkooijen Helena M, van der Heide Uulke A, Kerkmeijer Linda G W 28 Dec 2021, In: Radiotherapy & Oncology. 167 , p. 127-132 6 p.
Gal Roxanne, Gregorowitsch Madelijn L., Emaus Marleen J., Blezer Erwin LA, van der Leij Femke, van Velzen Sanne GM, van Tol-Geerdink Julia J., Išgum Ivana, Verkooijen Helena M. Dec 2021, In: International Journal of Cardiology: Cardiovascular Risk and Prevention. 11
Versteeg Anne L, Gal Roxanne, Charest-Morin Raphaele, Verlaan Jorrit-Jan, Wessels Hester, Fisher Charles G, Verkooijen Helena M Dec 2021, In: BMC Cancer. 21 , p. 1-8
Derksen Jeroen W G, Vink Geraldine R, Elferink Marloes A G, Roodhart Jeanine M L, Verkooijen Helena M, van Grevenstein Wilhelmina M U, Siersema Peter D, May Anne M, Koopman Miriam, Dec 2021, In: Scientific Reports. 11 , p. 1-12